SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-216780
Filing Date
2022-08-10
Accepted
2022-08-10 07:08:25
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d295365d10q.htm   iXBRL 10-Q 1738566
2 EX-10.1 d295365dex101.htm EX-10.1 30490
3 EX-31.1 d295365dex311.htm EX-31.1 11220
4 EX-31.2 d295365dex312.htm EX-31.2 11242
5 EX-32.1 d295365dex321.htm EX-32.1 3395
6 EX-32.2 d295365dex322.htm EX-32.2 3399
  Complete submission text file 0001193125-22-216780.txt   4776328

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20220630.xsd EX-101.SCH 27153
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nuvl-20220630_cal.xml EX-101.CAL 24241
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvl-20220630_def.xml EX-101.DEF 158011
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20220630_lab.xml EX-101.LAB 237345
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20220630_pre.xml EX-101.PRE 198522
46 EXTRACTED XBRL INSTANCE DOCUMENT d295365d10q_htm.xml XML 539832
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 221150383
SIC: 2834 Pharmaceutical Preparations